Gene Query: FZD5

Dataset Description Geneva Score
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 84.73
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 83.08
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 83.08
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 83.0
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 68.54
RNA-Seq from early time points in the kidney differentiation protocol 67.73
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 62.88
SUV420H2 knockdown in PANC-1 49.31
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 49.04
Ectoderm specification of H1 human embryonic stem cells 48.81
Dtx3L and Androgen Signaling in Prostate Cancer 48.53
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 47.64
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 47.64
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 47.39
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 47.39
Paxillin regulates genomic networks in prostate cancer [C4-2] 45.68
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 45.64
miR-93 Targets in Human Endothelial Cells 44.35
Subtle asymmetry of gene expression in embryonic and foetal human brains 42.05
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 40.71
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 39.79
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 39.78
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 39.78
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 38.73
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 37.25
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 35.98
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 35.95
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 34.64
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 34.09
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 33.99
An RNA-centric dissection of host complexes controlling flavivirus infection 33.99
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 33.5
Depicting early human development and germ cell origin with porcine embryos 31.89
RNA-seq in HepG2 and IMR90 cells 30.83
Evolution of a transcriptional regulator from a transmembrane nucleoporin 30.83
DIGIT regulates endoderm differentiation of human embryonic stem cells 30.78
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 30.35
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 30.1
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 30.1
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 29.56
Transcriptome analysis of kidney organoids 29.51
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 29.4
Cerebellar differentiation in Ataxia-Telangiectasia 28.37
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 28.28
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 28.28
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 27.9
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 27.63
Gene expressions of H9s in different culture systems 27.27
Functional astrocytes differentiated from hiPSCs 27.15
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 26.67
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 26.49
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 26.02
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 25.7
Nonpregnant and term pregnant human myometrial tissues 25.7
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 25.52
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 25.51
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 25.51
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 24.96
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 24.8
Hepatitis C virus functionally sequesters miR-122 24.37
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 24.37
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 24.25
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 24.15
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 24.15
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 23.92
BI Human Reference Epigenome Mapping Project 23.74
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 22.47
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 22.47
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 22.39
Differentially expressed vascular development genes for iPSC-ECs from CDI 22.08
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 21.86
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 20.8
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 20.45
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 20.44
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 20.37
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 20.01
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 19.68
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 19.6
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 19.17
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 19.16
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 19.14
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 19.05
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 18.8
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 18.78
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 18.78
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 18.77
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 18.72
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 18.53
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 18.46
Examining serotonergic neuron differentiation from human iPSCs 18.33
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 18.26
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 18.26
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 18.23
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 18.13
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 18.12
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 18.12
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 18.0
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 17.62
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 17.46
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 17.32
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 17.02
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 17.02
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 16.91
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 16.88
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 16.2
Gene expression analysis of dengue-infected cells 15.63
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 15.62
Changes in human endometrial gland transcriptome over the window of implantation 15.2
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 14.93
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 14.93
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 14.69
RNA polymerase in pre-B-ALL cell lines 14.52
Novel Targeting of Transcription and Metabolism in Glioblastoma 14.47
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 14.46
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 14.37
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 14.37
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 14.04
Global expression profiles in cardiac progenitor cells generated by ISX-9 13.95
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 13.95
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 13.87
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 13.85
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 13.77
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 13.4
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 13.4
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 13.34
Epigenome regulation during epidermal lineage commitment [RNA-seq] 13.28
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 13.28
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 13.2
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 13.1
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 13.1
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 13.09
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 12.97
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 12.96
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 12.94
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 12.94
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 12.8
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 12.74
Next Generation Sequencing of human SMA and healthy control Motor Neurons 12.74
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 12.73
HNRNPL and its RNA Targets in Prostate Cancer 12.72
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 12.72
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 12.71
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 12.65
Lineage specific differentiation is influenced by state of human pluripotency 12.65
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 12.48
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 12.37
Region-specific Innate Antiviral Responses of the Human Epididymis 12.33
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 12.3
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 12.17
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 12.13
Developmental stage specific chromosome architecture in human erythroid cells 12.13
High-throughput sequencing of PROMPT-enriched samples. 12.03
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 12.01
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 11.88
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 11.82
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 11.81
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 11.8
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 11.75
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 11.74
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 11.74
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 11.67
Global analyses of the effect of different cellular contexts on microRNA targeting 11.67
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 11.65
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 11.63
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 11.61
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 11.55
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 11.48
Identification of global XBP1s target gene expression in human prostate cancer cells 11.43
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 11.36
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 11.33
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 11.24
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 11.11
RNAseq analysis of ESRP regulated splicing events in prostate cancer 11.07
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 10.88
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 10.87
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 10.83
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 10.83
RNA-seq of naive and primed ES cells (NHSM) 10.58
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 10.56
iPSC-Derived Cholangiocytes 10.56
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 10.55
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 10.55
High-efficiency RNA-based reprogramming of human primary fibroblasts 10.54
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 10.52
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 10.41
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 10.41
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 10.39
Selective suppression of endothelial cytokine production by progesterone receptor 10.39
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 10.35
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 10.34
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 10.34
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 10.2
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 10.19
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 9.99
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 9.95
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 9.95
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 9.93
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 9.93
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 9.87
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 9.84
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 9.72
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 9.63
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 9.63
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 9.63
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 9.61
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 9.46
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 9.31
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 9.28
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 8.93
Gene expression patterns define the hepatocyte-like cells derived by different strategies 8.93
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 8.91
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 8.87
Sensing self and nonself circular RNAs 8.85
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 8.84
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 8.8
RNA-sequencing 8.79
In vitro modeling of human germ cell development using pluripotent stem cells 8.71
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 8.7
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 8.7
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 8.57
The comparison of high-throughput single-cell RNA-seq methods 8.56
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 8.55
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 8.53
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.52
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 8.48
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 8.48
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 8.46
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 8.46
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 8.46
Disruption of GRIN2B impairs differentiation in human neurons 8.46
Role for citron kinase in prostate cancer growth 8.37
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 8.36
High-throughput sequencing of pluripotent cells 8.33
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 8.25
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 8.2
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 8.18
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 8.18
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 8.16
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 8.16
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 8.07
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 8.07
Derivation and differentiation of haploid human embryonic stem cells 8.07
Transcriptome analysis of human lung epithelial cells 8.03
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 7.99
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 7.86
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 7.82
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 7.77
Engineering Patient-Specific Tissue Implants 7.76
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 7.75
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 7.74
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 7.74
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 7.73
FGF2 regulation of gene expression in stable inducible Neurons 7.72
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 7.69
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 7.69
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 7.69
Epigenome regulation during epidermal lineage commitment 7.68
WNT signaling memory is required for ACTIVIN to function as a morphogen 7.59
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 7.56
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 7.53
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 7.51
Transcriptional responses of human insulinoma cells to acute cytokine exposure 7.5
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 7.48
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 7.42
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 7.4
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 7.35
Transcriptome analysis reveals differential splicing events in IPF lung tissue 7.29
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 7.26
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 7.22
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 7.22
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 7.18
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 7.15
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 7.13
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 7.08
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.08
A prostate cancer chromatin interaction map 7.06
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 7.04
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 7.04
Genome-wide mapping of TEL-AML1 targets in acute leukemia 6.97
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 6.96
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.85
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 6.84
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 6.84
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.84
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 6.82
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 6.77
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 6.77
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 6.77
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 6.74
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 6.72
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 6.71
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 6.71
Global transcriptome analysis of WT versus HEB-/- hESCs 6.64
RNAseq Analysis in glioblastoma cells treated with Mepazine 6.63
RNA-seq of SCLC PDX models treated with EP 6.62
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 6.61
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 6.6
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 6.59
RNA-sequencing in irradiated and normal A549 cells. 6.53
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 6.53
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 6.52
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 6.47
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 6.34
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 6.33
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 6.26
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 6.26
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 6.24
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 6.2
Gene profiling of human adult and pediatric liver cancer cells 6.08
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.08
RNA-sequencing of human liver tissue 6.03
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 6.02
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 5.91
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 5.88
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 5.88
5.86
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.85
Postnatal lipids drive hepatocyte maturation 5.82
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 5.8
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 5.79
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 5.76
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 5.71
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 5.71
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 5.62
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 5.62
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 5.62
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 5.62
Expression by CD133+ cells isolated from the adult human exocrine pancreas 5.57
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 5.47
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 5.47
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 5.41
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 5.41
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 5.38
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 5.31
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 5.31
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 5.3
RNA seq analysis of human Fetal and adult derived Enterospheres 5.27
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.23
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 5.15
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 5.14
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 5.12
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 5.07
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 5.05
Dynamic reorganization of nuclear architecture during human cardiogenesis 5.05
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.99
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 4.96
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 4.91
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 4.9
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 4.89
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 4.89
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 4.86
Evaluating pre-clinical models for studying NASH driven HCC. 4.83
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 4.82
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 4.82
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 4.73
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.67
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.67
Glioblastoma stem cells infected by ZIKA virus 4.53
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 4.5
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.48
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.48
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 4.47
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 4.44
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 4.43
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 4.41
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 4.4
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 4.4
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 4.4
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 4.38
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.36
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 4.35
Triple vectors expand AAV transfer capacity in the retina 4.11
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 4.06
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 3.94
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 3.78
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 3.71
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 3.7
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 3.7
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 3.69
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 3.67
The gene expression profiles of gallbladder cancer 3.58
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 3.57
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.56
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 3.56
MRTF activates TEAD-YAP target gene expression 3.5
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 3.48
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 3.48
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 3.47
A single-cell transcriptome atlas of the human pancreas 3.47
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 3.45
The expression profiles of GBC liver metastasis 3.44
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 3.4
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 3.37
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 3.37
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 3.34
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.31
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 3.26
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.24
RNA-seq analysis of RALD iPSCs after in vitro differentiation 3.23
Loss of endometrial plasticity in recurrent pregnancy loss 3.21
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 3.21
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 3.2
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 3.13
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.13
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.09
AMPK signaling for naïve pluripotency [Hs] 2.99
AMPK signaling for naïve pluripotency 2.99
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 2.97
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 2.97
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.96
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.87
Reprogrammed myeloid cell transcriptomes in NSCLC 2.81
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.72
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 2.61
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 2.59
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 2.54
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 2.54
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.53
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 2.5
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.46
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 2.39
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 2.29
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 2.25
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 2.25
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 2.18
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 2.18
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 2.03
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 2.03
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 2.02
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 1.99
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.95
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 1.94
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.91
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.78
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.73
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.72
RNA splicing alteration on glioblastoma and normal neural stem cells 1.63
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.6
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.59
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.55
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.53
The MEF2B Regulatory Network 1.53
The MEF2B Regulatory Network - RNA-seq data 1.53
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.5
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.5
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.48
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.47
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.47
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 1.44
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.38
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 1.35
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.32
Common inflammatory pathways between NEC and Crohn's disease 1.32
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.28
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 1.15
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 1.15
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 1.15
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 1.12
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.04
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.04
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 1.03
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 1.03
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.9
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 0.9
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.89
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.89
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 0.89
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.88
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.88
Finding missing proteins from epigenetically manipulated human cells 0.87
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.82
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.79
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.79
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.76
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.75
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.75
Expression profiles of the four human major ectodermal lineages 0.75
MARS Seq data from human cortical organoids 0.73
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 0.73
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 0.73
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.68
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.68
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.57
Hepatic transcriptome of pediatric hepatoblastoma. 0.45
Transcriptome landscape of HeLa response upon triamcinolone acetonide 0.43
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.43
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 0.42
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.4
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.39
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.39
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 0.36
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.35
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 0.27
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.19
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.16
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.13
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.09
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.02
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.01
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation